Transverse myelitis pathophysiology describes the complex cascade of inflammatory and cellular events that lead to spinal cord damage. This condition is characterized by acute inflammation of the bilateral spinal cord tissue, disrupting the communication between the brain and the body. Understanding the underlying mechanisms is essential for clinicians to effectively diagnose and manage this often-debilitating neurological disorder.
Defining the Inflammatory Cascade
The core of transverse myelitis pathophysiology lies in an inappropriate immune response. In many cases, the body's immune system mistakenly identifies components of the spinal cord as foreign invaders. This triggers the activation of autoreactive lymphocytes and the release of pro-inflammatory cytokines, initiating a cascade that leads to blood-spinal cord barrier breakdown and subsequent tissue injury.
The Role of the Blood-Spinal Cord Barrier
A critical event in the pathology is the disruption of the blood-spinal cord barrier (BSCB). Normally, this barrier tightly regulates the movement of cells and solutes from the blood into the central nervous system. During an inflammatory episode, the BSCB becomes permeable, allowing immune cells like T-cells and macrophages to infiltrate the spinal cord parenchyma. This infiltration is a key driver of the neurological deficits observed in patients.
Cellular and Molecular Mechanisms
Beyond the initial immune activation, specific cellular players contribute significantly to the damage. Microglia, the resident immune cells of the central nervous system, become activated and phagocytic, potentially attacking healthy neural tissue. Furthermore, the release of excitotoxic molecules and reactive oxygen species exacerbates neuronal injury, leading to axonal degeneration and demyelination that form the basis of persistent symptoms.
Distinguishing Underlying Causes
The pathophysiology is often categorized by its origin, which can be idiopathic or secondary to other conditions. When associated with autoimmune disorders like neuromyelitis optica spectrum disorder (NMOSD) or myelin oligodendrocyte glycoprotein antibody disease (MOGAD), the target is specific neural antigens. Conversely, paraneoplastic transverse myelitis occurs when cancerous tumors elsewhere in the body trigger an immune cross-reaction that mistakenly attacks the spinal cord.
Patterns of Spinal Cord Involvement
Anatomically, the inflammation in transverse myelitis pathophysiology typically affects a distinct segment of the spinal cord, often spanning multiple contiguous segments. This focal inflammation can manifest in different cord regions, including the cervical, thoracic, or lumbosacral areas. The specific location dictates the clinical presentation, ranging from limb weakness to sensory loss and autonomic dysfunction.
Progression and Chronic Changes
In the acute phase, the pathophysiology is dominated by active inflammation and cytotoxic events. However, if the inflammatory process is not resolved, it can transition into a chronic phase. Here, gliosis and scarring, or gliosis, form a physical and chemical environment that inhibits neural regeneration. This maladaptive remodeling contributes to the long-term neurological deficits and disability faced by many individuals.
